Brain imaging and depression research with psychedelics
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.
Biography
Robin Carhart-Harris studies the brain effects of LSD, psilocybin (magic mushrooms), and MDMA. Most recently he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression.
OPEN Foundation
Share This Post
get the latest
The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!
By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.
